Market Report
Location Sciences ropes in Andy Roberts to strengthen advisory panel
Location data verification and analytics provider Location Sciences announced the appointment of Andy Roberts to strengthen its advisory panel on Monday.
Providence agrees another extension as APEC submits Barryroe payment
Ireland-based energy company Providence Resources released a commercial and operational update in relation to Standard Exploration Licence 1/11 on Monday, which contains the Barryroe oil accumulation.
Grainger starts work on latest Leeds investment
Landlord Grainger has started work on its latest investment in Leeds after satisfying certain contractual conditions.
Tertiary Minerals reports two target zones for zinc-silver at Paymaster
Tertiary Minerals advised on Monday that initial follow-up field reconnaissance of soil anomalies at its recently-acquired Paymaster Polymetallic Project in Nevada had identified two zones of zinc-silver mineralisation for follow-up exploration and drilling.
Pershing Square announces $400m private bond placement
Pershing Square Holdings announced a fully-committed private placement of $400m of bonds on Monday, with a coupon of 4. 95%, maturing on 15 July 2039.
IP Group upbeat on news from portfolio firms Ceres Power and Istesso
IP Group confirmed on Monday that its portfolio company Ceres Power Holdings has signed a collaboration and licensing agreement with Doosan Corporation to jointly develop SOFC distributed power systems, initially targeted at the Korean commercial building market.
AstraZeneca gets complete response from FDA over 'Farxiga'
AstraZeneca announced on Monday that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the supplemental New Drug Application for ‘Farxiga’ (dapagliflozin) as an adjunct treatment to insulin to improve glycaemic control in adult patients with type-1 diabetes, when insulin alone does not provide adequate glycaemic control.
GlaxoSmithKline reveals positive results from 'Zejula' ovarian cancer trial
GlaxoSmithKline announced positive results from its ‘PRIMA’ phase 3 randomised, double-blind, placebo-controlled study of ‘Zejula’ (niraparib) as a maintenance therapy in patients with first-line ovarian cancer following platinum-based chemotherapy on Monday.
London open: Stocks edge up as investors mull China data; US earnings season eyed
London stocks nudged up in early trade on Monday as investors mulled mixed Chinese economic data and looked ahead to the start of the US earnings season.
Chinese economic growth slows to 27-year low
Chinese economic growth eased to its weakest pace in 27 years in the second quarter, according to data released by the country’s statistics bureau on Monday.
Sports Direct delays publication of preliminary results, Bank of Georgia gets loan for local currency funding
London open The FTSE 100 is expected to open two points higher on Monday, having closed down 0. 05% at 7,505. 97 on Friday.
London pre-open: Stocks set for muted open after mixed China data
London stocks were set for a muted open on Monday as investors digested some mixed Chinese economic data.
Monday newspaper round-up: UK shoppers, Chinese growth, Boeing
Shoppers deserted UK high streets during June as the washout weather and continuing Brexit uncertainty helped drive store visits down to a seven-year low for the month. The “summer slump” took a particularly heavy toll on high streets, with shopping centres also badly affected, according to the British Retail Consortium’s (BRC) monthly footfall tracker for the period from 26 May to 29 June. - Guardian.